Rydex Biotechnology Fund Class Investor (RYOIX) - Health fund with $132.34 Million in assets. The fund allocates 37.71% of its portfolio to its top 10 holdings. It primarily invests in averagemarketcap cap stocks , with a focus on the cash and equivalents sector.
The largest holding in the fund is AbbVie, Inc. at 7.53% of total assets. This is followed by Amgen, Inc. (4.96%) and Gilead Sciences, Inc. (4.49%).
| Name | Weight | Owned | Change |
|---|---|---|---|
| AbbVie, Inc. | 7.53% | - | - |
| Amgen, Inc. | 4.96% | - | - |
| Gilead Sciences, Inc. | 4.49% | - | - |
| Regeneron Pharmaceuticals, Inc. | 3.65% | - | - |
| Vertex Pharmaceuticals, Inc. | 4.41% | - | - |
| Alnylam Pharmaceuticals, Inc. | 2.90% | - | - |
| Corteva, Inc. | 2.81% | - | - |
| Biogen, Inc. | 2.09% | - | - |
| Moderna, Inc. | 2.65% | - | - |
| AstraZeneca plc | 2.22% | - | - |
| BeiGene Ltd. | 2.40% | - | - |
| Insmed, Inc. | 2.32% | - | - |
| BeOne Medicines Ltd. | 2.04% | - | - |
| Natera, Inc. | 2.27% | - | - |
| AbbVie Inc. COM | 7.39% | - | - |
| Amgen Inc. COM | 5.23% | - | - |
| Gilead Sciences Inc. COM | 4.96% | - | - |
| Vertex Pharmaceuticals Incorporated COM | 4.01% | - | - |
| Regeneron Pharmaceuticals, Inc. COM | 3.56% | - | - |
| Alnylam Pharmaceuticals Inc. COM | 2.60% | - | - |
| Insmed Inc COM PAR $.01 | 2.45% | - | - |
| BeOne Medicines Ltd. SPONSORED ADS | 2.29% | - | - |
| Natera Inc. COM | 2.09% | - | - |
| United Therapeutics Corporation COM | 2.07% | - | - |
| ABBVIE INC COM | 8.17% | - | - |
| AMGEN INC COM | 5.05% | - | - |
| GILEAD SCIENCES INC COM | 4.49% | - | - |
| VERTEX PHARMACEUTICALS INC COM | 4.32% | - | - |
| REGENERON PHARMACEUTICALS INC COM | 2.93% | - | - |
| REVOLUTION MEDICINES INC COM | 2.48% | - | - |
| ALNYLAM PHARMACEUTICALS INC COM | 2.36% | - | - |
| BEONE MEDICINES LTD SPONSORED ADS | 2.17% | - | - |
| MODERNA INC COM | 2.15% | - | - |
| BIOGEN INC COM | 2.13% | - | - |